Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|August 1, 1992
Antigenic expression of B-cell chronic lymphocytic leukemic cell linesG E Marti, V Zenger, M Brown, et al.
Neuropharmacology|April 29, 2020
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45S Bilel, N J Azevedo, R Arfè, et al.
Anti-Cancer Drugs|January 8, 2008
Antioxidants block proteasome inhibitor function in endometrial carcinoma cellsDavid Llobet, Nuria Eritja, Mario Encinas, et al.
Oncogenesis|August 22, 2019
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancerHaitang Yang, Shun-Qing Liang, Duo Xu, et al.
Seminars in Diagnostic Pathology|November 19, 2008
Targeted therapies in gynecologic cancers and melanomaEugenia Ortega, Rosa M Marti, Andree Yeramian, et al.
The British Journal of Surgery|March 12, 2014
Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapyP Myrelid, M Marti-Gallostra, S Ashraf, et al.
JTO Clinical and Research Reports|May 8, 2024
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural MesotheliomaDuo Xu, Yanyun Gao, Haitang Yang, et al.
Revista De Calidad Asistencial : Organo De La Sociedad Espanola De Calidad Asistencial|June 9, 2016
[Development and evolution of a balanced scorecard in primary health care: Lessons learned]E Bartolomé-Benito, J Jiménez-Carramiñana, L Sánchez-Perruca, et al.
Theranostics|January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesotheliomaHaitang Yang, Sabina Berezowska, Patrick Dorn, et al.
Biosensors & Bioelectronics|September 28, 2011
Optical microchip array biosensor for multiplexed detection of bio-hazardous agentsD Bhatta, A A Michel, M Marti Villalba, et al.
Pageof 19